Gynecologic

Gynecologic Cancer Treatment Trials

Protocol
Number

Title

ID

GOG
0263

The purpose of this study is to determine whether AMG 386 or AMG 386 Placebo in combination with Paclitaxel and Carboplatin are effective in the treatment of ovarian cancer.

Learn more.

NCT01493505
GOG
0233

This phase I/II trial is studying how well fludeoxyglucose F 18 PET scan, CT scan, and ferumoxtran-10 MRI scan finds lymph node metastasis before undergoing chemotherapy and radiation therapy in patients with locally advanced cervical cancer or high-risk endometrial cancer.

Learn more.

NCT00416455
GOG
0212

A Randomized Phase III Trial of Maintenance Chemotherapy Comparing 12 Monthly Cycles of Single Agent Paclitaxel or Xyotax (CT-2103) (IND# 70177), Versus No Treatment Until Documented Relapse in Women With Advanced Ovarian or Primary Peritoneal or Fallopian Tube Cancer Who Achieve a Complete Clinical Response to Primary Platinum/Taxane Chemotherapy

Learn more.

NCT00108745
GOG
0273

Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Learn more.

NCT01366183
GOG
0261

A Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Ifosfamide Plus Paclitaxel in Chemotherapy-Naive Patients With Newly Diagnosed Stage I-IV, Persistent or Recurrent Carcinosarcoma (Mixed Mesodermal Tumors) of the Uterus or Ovary

Learn more. 

NCT00954174
GOG
0274

A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial

Learn more.

NCT01414608
GOG
0263

Randomized Phase III Clinical Trial of Adjuvant Radiation vs. Chemoradiation in Intermediated Risk Stage I/IIA Cervical Cancer Treated w/ Initial Radical Hysterectomy & Pelvic Lymphadenectomy

Learn more.

NCT01101451
GOG
0241

A Multi-Center Phase III Trial of Open Label of Carboplatin & Paclitaxel +/-NCI Supplied Agent: Bevacizumab Compared with Oxaliplatin & Capecitabine +/- Bevacizumab as First Line Chemotherapy in Patients with Mucinous Epithelial Ovarian or Fallopian Tube Cancer (MEOC)

Learn more.

NCT01081262
GOG 0258

A Randomized Phase III Trial of Cisplatin & Tumor Volume Directed Irradiation followed by Carboplatin & Paclitaxel vs Carboplatin & Paclitaxel for Optimally Advanced Endometrial Carcinoma

Learn more.

NCT00942357
GOG 0249

A Phase III Trial of Pelvic Radiation Therapy vs. Vaginal Cuff Brachytherapy Followed by Paclitaxel/Carboplatin Chemotherapy in Patients with High Risk, Early Stage Endometrial Carcinoma

Learn more.

NCT00807768